TFX Teleflex Inc

$126.87 +1.49%

Healthcare · Surgical & Medical Instruments & Apparatus

Teleflex Inc (TFX) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $5.6 billion. Shares last traded at $126.87, 10.0% below their 52-week high. Over the past year the stock is up 8.0%. Net profit margin is -45.4%, below the peer median of -7.6%. Revenue grew 17.2% year over year. The shares yield 1.1% in dividends.

Market Cap

$5.6B

Shares Out

44.3M

EPS (TTM)

$-20.25

P/E Ratio

—

P/S Ratio

2.82

P/B Ratio

1.82

Dividend / Share

$1.36

Dividend Yield

1.07%

52-Week High

$140.91

52-Week Low

$100.18

Volume

28,823

Avg Vol (3m)

57,277.333

Performance

-1.75%

-4.46%

+18.44%

+1.59%

YTD

+3.61%

+7.98%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.83

SMA (50)

$129.67

SMA (200)

$120.33

Price vs SMA50

-2.16%

Price vs SMA200

+5.44%

ATR (14)

$3.88

Financials

Revenue

$2.0B

Net Income

$-906M

Gross Margin

56.2%

Operating Margin

5.9%

Net Margin

-45.4%

Return on Equity

-29.4%

Return on Assets

-13.4%

Current Ratio

2.55

Debt / Equity

0.82

Revenue Growth (YoY)

+17.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.18	2026-05-07
FY 2025	$-20.25	2026-02-27
FY 2025	$-9.24	2026-02-27
FY 2025	$2.77	2026-02-27
Q1 2026	$2.07	2026-05-07
FY 2025	$1.48	2026-02-27

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

TFX vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

2.82 / 2.52 med

+12% premium

Net margin vs peers

-45.4% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.